
News|Articles|May 1, 2024
Espansione Group: Illuminating the Future of AMD Treatment: The Breakthrough of LightWave I Trial with PBM Technology
Advertisement
Advertorial: Espansione Group: Illuminating the Future of AMD Treatment:
The Breakthrough of LightWave I Trial with PBM Technology
Espansione Group, a global leader in photobiomodulation (PBM), has marked its presence with significant advancements in ophthalmology and beyond. After a decade where it has made significant strides, especially in the anterior segment of the eye, the company is now pioneering its application for the posterior pole, venturing into new territory with treatments for Age-Related Macular Degeneration (AMD), specifically in its early stages (i.e.,dry AMD).
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
2
Oku Digital Health launches from Topcon to link eye care, primary care
3
EURETINA 2026: Optogenetic therapy MCO-010 aims to restore vision in advanced macular disease
4
Real-world VOYAGER data on faricimab in nAMD, DME, RVO at EURETINA 2026
5



















